1. Home
  2. NAUT vs OPP Comparison

NAUT vs OPP Comparison

Compare NAUT & OPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAUT
    SELLHOLDBUYas of 34 minutes ago
  • OPP
    SELLHOLDBUYas of 34 minutes ago
  • Stock Information
  • Founded
  • NAUT 2016
  • OPP 2010
  • Country
  • NAUT United States
  • OPP United States
  • Employees
  • NAUT N/A
  • OPP N/A
  • Industry
  • NAUT Biotechnology: Laboratory Analytical Instruments
  • OPP Finance/Investors Services
  • Sector
  • NAUT Industrials
  • OPP Finance
  • Exchange
  • NAUT Nasdaq
  • OPP Nasdaq
  • Market Cap
  • NAUT 188.3M
  • OPP 204.1M
  • IPO Year
  • NAUT N/A
  • OPP N/A
  • Fundamental
  • Price
  • NAUT $0.86
  • OPP $8.63
  • Analyst Decision
  • NAUT Hold
  • OPP
  • Analyst Count
  • NAUT 3
  • OPP 0
  • Target Price
  • NAUT $3.58
  • OPP N/A
  • AVG Volume (30 Days)
  • NAUT 148.8K
  • OPP 108.0K
  • Earning Date
  • NAUT 04-29-2025
  • OPP 01-01-0001
  • Dividend Yield
  • NAUT N/A
  • OPP 14.41%
  • EPS Growth
  • NAUT N/A
  • OPP N/A
  • EPS
  • NAUT N/A
  • OPP N/A
  • Revenue
  • NAUT N/A
  • OPP N/A
  • Revenue This Year
  • NAUT N/A
  • OPP N/A
  • Revenue Next Year
  • NAUT N/A
  • OPP N/A
  • P/E Ratio
  • NAUT N/A
  • OPP N/A
  • Revenue Growth
  • NAUT N/A
  • OPP N/A
  • 52 Week Low
  • NAUT $0.82
  • OPP $7.26
  • 52 Week High
  • NAUT $3.09
  • OPP $8.83
  • Technical
  • Relative Strength Index (RSI)
  • NAUT 26.50
  • OPP 48.25
  • Support Level
  • NAUT $0.82
  • OPP $8.55
  • Resistance Level
  • NAUT $1.06
  • OPP $8.74
  • Average True Range (ATR)
  • NAUT 0.08
  • OPP 0.09
  • MACD
  • NAUT 0.00
  • OPP -0.01
  • Stochastic Oscillator
  • NAUT 7.51
  • OPP 35.71

Stock Price Comparison Chart: NAUT vs OPP

NAUT
OPP
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April024681012141618NAUT VS OPP

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. It has built a prototype of a single-molecule instrument, Proteomic Analysis System.

About OPP RiverNorth/DoubleLine Strategic Opportunity Fund Inc.

RiverNorth/DoubleLine Strategic Opportunity Fund Inc is a closed-end management investment company. The company's investment objective is to seek current income and overall total return.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use